Amphetamine Patent Expiration
Amphetamine was first introduced by Neos Therapeutics
Amphetamine Patents
Given below is the list of patents protecting Amphetamine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Adzenys Er | US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Er | US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Er | US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps Inc |
| Adzenys Xr-odt | US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US8840924 | Compositions and methods of making rapidly dissolving ionically masked formulations | Apr 09, 2026 | Neos Theraps |
| Adzenys Xr-odt | US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps |
| Adzenys Xr-odt | US9839619 | Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles | Jun 28, 2032 | Neos Theraps |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Amphetamine Generics
Several generic applications have been filed for Amphetamine.
Given below is the list of companies who have filed for Amphetamine generic.
1. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 6 different strengths of generic version for Amphetamine. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 3.1MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |
| EQ 6.3MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |
| EQ 9.4MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |
| EQ 12.5MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |
| EQ 15.7MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |
| EQ 18.8MG BASE | tablet, orally disintegrating, extended release | Discontinued | ORAL | N/A | Jun 22, 2023 |